Cannabinoids have garnered the attention of many scientists and pharmacologists in recent years, with the importance being focused on the primary constituents of cannabis such as delta-9-tetrahydrocannabinol (D9-THC), Cannabidiol (CBD), cannabinol (CBN), and even more recently delta-8-tetrahydrocannabinol (D8-THC), testing the uses of these cannabinoids to treat diseases and mental issues such as chronic pain, multiple sclerosis, epilepsy, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease, post-traumatic stress disorder, anxiety, sleep, opioid use disorder, Tourette's syndrome, cancer and cancer-related illness, glaucoma, and inflammatory bowel disease . With over 150 cannabinoids reported in the plant and a select few being investigated, countless others are left uninvestigated .